Hairy Cell Leukemia (HCL)

Also known as: Leukemia, Hairy Cell / Hairy cell leukaemia / Hairy Cell Leukemia / Leukemias, Hairy Cell / Leukemic reticuloendotheliosis / Leukaemic reticuloendotheliosis

DrugDrug NameDrug Description
DB00242CladribineA purine antimetabolite used for the management of relapsing forms of Multiple Sclerosis (MS), used in patients who have not responded to or who were unable to tolerate alternative MS drugs.
DB00105Interferon alfa-2bA form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma.
DB12688Moxetumomab PasudotoxA CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment.
DB00552PentostatinAn adenosine deaminase inhibitor used to treat hairy cell leukemia.